Indications and uses
For the temporary relief of bedwetting in children (nocturnal enuresis).
For the temporary relief of bedwetting in children (nocturnal enuresis).
Dissolve 2 tablets under the tongue at dinner and 2 more at bedtime. Store in a cool dry place.
Causticum 6C, Equisetum Hyemale 6C, Sepia 6C.
For the temporary relief of bedwetting in children (nocturnal enuresis).
Do not use if safety seal is broken or missing.
A physician should always be consulted to rule out serious causes.
If pregnant or breast feeding, ask a physician before use. If symptoms persist, consult a physician.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Active ingredients are prepared in accordance with the Homeopathic Pharmacopoeia of the United States (HPUS) and are non-toxic with no known side effects.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Dissolve 2 tablets under the tongue at dinner and 2 more at bedtime. Store in a cool dry place.
For the temporary relief of bedwetting in children (nocturnal enuresis).
Lactose, Magnesium Stearate, Microcrystalline Cellulose
For more information please visit:
Quality manufactured for and distributed by:
Peerless Homeopathic
PO Box 5038 Charlottesville, VA 22905
DriNites
Bedwetting Relief
100% Natural
No Side Effects
Dissolving Tabs
Homeopathic 100 Tablets
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 71094-0002 | 71094-0002-1 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CAUSTICUM | DD5FO1WKFU | ACTIB |
| EQUISETUM HYEMALE WHOLE | 59677RXH25 | ACTIB |
| SEPIA OFFICINALIS JUICE | QDL83WN8C2 | ACTIB |
| LACTOSE | J2B2A4N98G | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| bef1aa21-2375-4df2-95bc-e7daf553ba90 | b83b014a-9543-4297-952c-bd54cd9abc0d | 2024-01-18 | Warnings | bef1aa21-2375-4df2-95bc-e7daf553ba90 b83b014a-9543-4297-952c-bd54cd9abc0d |
Adverse event summaries are temporarily unavailable. Other product information remains available.